AI drug discovery is largely overhyped, with most breakthroughs occurring in silico and failing in vivo, according to an analysis of the field. The article highlights that while AI excels at target id…
AI-designed functional viruses represent a major advance in biotechnology, moving from descriptive to prescriptive models that can generate novel viral sequences. This enables designer viruses for tar…
Jeff Dean, former Google AI leader, raised $1 billion in seed funding for Discovery Loop at a $10 billion valuation to automate scientific discovery. The company aims to build a generalized system tha…
Google shut down AlphaFold, DeepMind's AI-powered protein structure prediction tool, and removed Demis Hassabis from his role directing DeepMind, according to reports from Engadget and Ars Technica. T…
A new blog post from Georeactor explores using AI to fold prion proteins, noting that while AI safety models like Claude and ChatGPT refused to assist, major prion protein research is publicly availab…
AI-driven drug discovery has attracted US$60 billion since 2019, with 175 AI-originated programmes entering human trials, yet none have won FDA approval; however, AI-discovered molecules clear Phase I…
Eric Schmidt, former CEO of Google and cofounder of Schmidt Sciences, and Suhas Mahesh, who leads the AI for science work at the AI Center of Schmidt Sciences, argue in an op-ed that AI agents, not ne…
Google DeepMind's AlphaFold, which won the 2024 Nobel Prize in Chemistry, may not be the best template for AI-driven scientific discovery because it required 53 years and roughly $21 billion to assemb…
Alphabet Inc. announced on August 5 that Demis Hassabis, co-founder and CEO of Google DeepMind, will transition to chairman of Alphabet's AI lab, while Jeff Dean, Google's Chief Scientist, is departin…
Discovery Loop, a new AI research company founded by Jeff Dean, Sanjay Ghemawat, Quoc Le, and Oriol Vinyals, announced its mission to automate scientific and engineering discovery using frontier AI mo…
Google has appointed Koray Kavukcuoglu to lead DeepMind as Demis Hassabis steps back from daily operations to focus on AGI strategy and scientific research, according to an unverified report. Hassabis…
Daphne Koller, founder and CEO of insitro, argues in a guest post that AI will not single-handedly cure diseases because human biology is still poorly understood, and most AI efforts focus on drug des…
Google DeepMind has disbanded its AlphaFold team, which developed the AI system that predicted protein structures for nearly all known proteins, and will pivot its focus to the Gemini large language m…
Google is discontinuing its Gemini 2.5 models, according to Google Cloud documentation, and reallocating resources from its AlphaFold team toward robotics development, coinciding with the launch of Ge…
Google DeepMind has disbanded the dedicated research team behind AlphaFold, the Nobel Prize-winning protein-structure prediction system, according to a Financial Times report. Nobel laureate John Jump…
Google has dismantled the original AlphaFold team, reassigning many researchers to Gemini and Isomorphic Labs, while several key members including Nobel laureate John Jumper left for Anthropic, accord…
Google DeepMind dissolved the team that built AlphaFold, but the AlphaFold Protein Structure Database remains operational and is hosted by EMBL-EBI, not Google, with no deprecation or sunset date. The…
Google DeepMind has dismantled the team behind its Nobel Prize-winning AlphaFold protein-folding AI, reassigning most original authors and losing nearly a quarter of them, including Nobel co-winner Jo…
Google DeepMind has disbanded its AlphaFold team, shifting focus to its Gemini AI model ecosystem, signaling a move away from specialized AI models toward multimodal LLM agents. The transition means p…
Google's DeepMind has restructured the AlphaFold team, shifting its focus from research to deployment of protein-folding predictions in drug discovery and materials science. The integration of researc…